The Evolving Threat of ESBL, AmpC, and KPC -lactamases - SWACM
The Evolving Threat of ESBL, AmpC, and KPC -lactamases - SWACM
The Evolving Threat of ESBL, AmpC, and KPC -lactamases - SWACM
SHOW LESS
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
New CLSI Breakpoints<br />
Susceptible Breakpoint Lowered 2010 (M100-S20)<br />
Cefazolin, cefotaxime, ceftriaxone, ceftizoxime (< 1 µg/ml)<br />
Ceftazidime, aztreonam (< 4 µg/ml)<br />
No Change in Breakpoint (M100-S20)<br />
Cefepime (< 8 µg/ml)
Change language